Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on October 9th, 2025 | 07:40 CEST
AI paves the way to the next blockbuster: The current situation at Novo Nordisk, NetraMark Holdings and Evotec
The pharmaceutical industry is at a historic turning point. Artificial intelligence is breaking through the lengthy and costly development cycles that have characterized the sector for decades. This technological quantum leap is revolutionizing drug discovery and promises to transform healthcare from the ground up. The first companies to master this AI revolution will be the biggest winners in a billion-dollar market. We therefore take a look at three companies that are already using AI today: the Danish pharmaceutical giant Novo Nordisk, AI specialist NetraMark Holdings for clinical studies, and the German research service provider Evotec, and analyze their current situation.
ReadCommented by Armin Schulz on October 9th, 2025 | 07:00 CEST
Almonty Industries' Raw material power brings Rheinmetall and Lockheed Martin into a new geopolitical era
Nations around the world are investing record sums in their defense capabilities. This defense boom is driving demand for critical raw materials to unprecedented heights. Suddenly, critical metals such as tungsten are at the center of global politics. They have become strategic commodities, with security of supply directly influencing military strength. This development is creating real momentum for companies covering the entire value chain, from mining to the defense industry to high-tech. Three stocks that perfectly embody this interplay between raw materials, production, and technology are Almonty Industries, Rheinmetall, and Lockheed Martin.
ReadCommented by Armin Schulz on October 8th, 2025 | 07:20 CEST
Gold rush! Your portfolio for the USD 4,000 mark: Barrick Mining, Kobo Resources and Newmont
The magical threshold of USD 4,000 per ounce is within reach. Driven by geopolitical crises, a weak US dollar, and the global wave of de-dollarization, investors are flocking to the safe haven of gold. This historic bull market, fueled by ongoing expectations of interest rate cuts, offers unprecedented momentum. But how can investors directly capitalize on this potential? The key lies in the right producers and explorers, who will benefit maximally from any further price increases. Companies such as Barrick Mining, Kobo Resources and Newmont are now in the spotlight.
ReadCommented by Armin Schulz on October 8th, 2025 | 07:10 CEST
The Uptober Bonus: How to leverage Coinbase, Nakiki, and Riot Platforms for the next price sprint
The perfect interplay of macroeconomic turmoil, institutional capital flows, and seasonal patterns is fueling a spectacular crypto boom. Bitcoin, at the forefront of this frenzy, is climbing to unimaginable heights and pulling the entire sector along with it. It is already a historic trend that Bitcoin tends to rise in October, hence the term "Uptober." In this euphoric market phase, three players are coming into particular focus, each poised to benefit directly from these dominant trends: a leading trading platform, an innovative altcoin protagonist, and an industrial-scale Bitcoin miner. The strategies of Coinbase, Nakiki, and Riot Platforms could be the key to profiting from this unprecedented rally.
ReadCommented by Armin Schulz on October 7th, 2025 | 07:20 CEST
Cancer research with billion-dollar potential: How Bayer, Vidac Pharma, and BioNTech could come into play
The oncology market is booming like no other. Driven by technological quantum leaps and, unfortunately, rising case numbers, cancer treatment is becoming a highly lucrative innovation engine. The sector is growing at double-digit rates every year. Experts predict that the global market volume will break the USD 1 trillion mark within the next decade. No wonder, then, that the race for the next therapeutic breakthroughs in personalized medicines and AI-supported active ingredients is heating up. Investors are focusing not only on established players like Bayer, but also on up-and-coming specialists such as Vidac Pharma and mRNA pioneers like BioNTech.
ReadCommented by Armin Schulz on October 7th, 2025 | 07:05 CEST
Steel, hydrogen, SMRs, renewable energy: How to cover all the megatrends with thyssenkrupp, First Hydrogen and RWE
The global industry is undergoing a radical transformation. Drivers include volatile supply chains, ambitious climate targets, and technological change. This tension is giving rise to new markets and unexpected winners. Some pioneers are already showing how this transformation can be turned into profit. They combine deep structural change with a green hydrogen economy and groundbreaking energy research. Three companies exemplify how this transformation can not only be mastered but also leveraged as an opportunity: thyssenkrupp, First Hydrogen, and RWE.
ReadCommented by Armin Schulz on October 3rd, 2025 | 07:05 CEST
BioNxt Solutions' pharmaceutical revolution: New ways of administering blockbuster drugs
Imagine chemotherapy without severe side effects or a blockbuster drug without needles. What sounds like a pipe dream is now becoming reality thanks to innovative drug delivery systems. They are revolutionizing billion-dollar markets from oncology to obesity therapy and laying the foundation for exponential growth. For investors, this technological breakthrough opens up a unique investment window. BioNxt Solutions is at the forefront of this movement.
ReadCommented by Armin Schulz on October 2nd, 2025 | 07:00 CEST
Buckle up for the new precious metals era: Barrick Mining, Silver North Resources, and First Majestic Silver in focus
The signs are pointing to a new precious metals era. Driven by geopolitical upheaval, persistent inflation, and unprecedented demand from central banks, gold and silver are reaching new record highs. While gold shines as a safe haven, silver is also benefiting from the industrial boom, for example, in solar technology. This unique constellation opens up extraordinary opportunities for investors. Against this backdrop, it is worth taking a closer look at three companies. We analyze industry leader Barrick Mining, the exploration company Silver North, and the gold and silver producer First Majestic Silver.
ReadCommented by Armin Schulz on October 1st, 2025 | 07:10 CEST
How BYD Leverages Its Lead, How Power Metallic Mines Benefits, and Why Mercedes-Benz Needs to Catch Up
The next phase of electromobility has begun. It is no longer vehicle sales that determine the winners and losers, but rather the fierce battle for the raw materials used in their construction. While demand for copper, lithium, nickel, and cobalt is exploding, supply bottlenecks and political dependencies threaten to slow down the profitable ramp-up. Those who secure the most valuable resources today will control the entire market tomorrow. Reason enough to take a closer look at the strategic moves of BYD, Power Metallic Mines, and Mercedes-Benz, which are now setting the course for the coming decade.
ReadCommented by Armin Schulz on October 1st, 2025 | 07:00 CEST
The hydrogen formula: How to position yourself in the billion-dollar market with Nel ASA, dynaCERT and Plug Power
Global industry is facing what is arguably the greatest transformation of our time. Driven by the push for climate neutrality, the hydrogen market is rapidly gaining momentum and attracting capital once again. After a period of consolidation, the recent stock market upturn signals a new phase of maturity. The range of technologies, from green production and cleantech applications to more efficient use of fossil resources, is enormous. This is precisely where the opportunity lies for investors to find tomorrow's winners in good time. We take a look at three companies, Nel ASA, dynaCERT, and Plug Power, and analyze their opportunities.
Read